The Roche towers in Basel. The pharmaceutical group overtook electrical engineering group ABB to claim first place for patent applications in Switzerland.
Keystone / Georgios Kefalas
Swiss companies filed almost seven times as many patent applications per million inhabitants last year as companies in the United States. The medical technology sector led the field.
After a slight decline due to Covid in 2020, patent applications in Europe rose again last year, the European Patent Office (EPO) said in a statementExternal link on Tuesday.
The Munich-based body received a total of 188,600 patent applications in 2021, an increase of 4.5% year-on-year, setting a new record. It registered 8,442 patent applications from Switzerland, up 3.9%.
The US remains the country with the highest number of patent applications (46,553), while patent filings from Chinese companies “continued to climb steeply”, increasing by 24% last year (16,665), the EPO said.
Per million inhabitants, however, Switzerland remains way out in the lead with 969 patent applications, followed by Sweden (488), Denmark (454), the Netherlands (383) and Finland (380). The US had 140 applications per million inhabitants and the UK 82.
More
More
Switzerland ranks among world leaders for trademark and patent filings
This content was published on
A record number of international patents were filed last year despite the Covid-19 pandemic.
At the European level the digital communication and information technology sector filed the most applications (15,400, 9.4%), followed by medical technology (15,231, 8.8%) and computer technology (14,671, 9.7%).
In Switzerland the medical technology sector applied for the most patents. This was followed by the consumer goods, metrology, electronic devices and machines, pharmaceuticals, chemistry and biotechnology sectors.
Among Swiss companies, Basel-based pharmaceutical group Roche overtook electrical engineering group ABB in first place. The two tobacco companies Japan Tobacco and Philip Morris were followed by Nestlé and Swatch Group.
Popular Stories
More
Workplace Switzerland
What lies ahead for Switzerland: an economic outlook for 2025
In banking, Switzerland can’t afford ‘model pupil syndrome’, says UBS CEO
This content was published on
UBS Group CEO Sergio Ermotti says competition between banks in Switzerland will continue even following the takeover of rival Credit Suisse.
Switzerland to chair international forum on migration
This content was published on
Switzerland will chair the Intergovernmental Consultations on Asylum, Refugees and Migration (IGC) in 2025, the government announced on Monday.
Y2K anniversary: Swiss preparations to dodge the millennium bug
This content was published on
The idea that computers around the world could fail at midnight on December 31, 1999 put many on alert. In the end, not much went wrong.
‘Switzerland needs a stable relationship with its neighbours,’ says foreign minister
This content was published on
"We are once again entering an 'America first, Europe first, Switzerland first' logic," Ignazio Cassis said in an interview published Monday.
Jimmy Carter supported Swiss-backed peace effort for Middle East
This content was published on
Former United States President Jimmy Carter maintained close ties with Switzerland and had expressed gratitude for the country's efforts on the Geneva peace initiative.
Swiss cowfighting championship at risk of being cancelled
This content was published on
Despite growing popularity, the national Hérens cowfighting championship could be cancelled in 2025 for lack of organisers.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Genome editing’s patent problem fuels concern for the future of food
This content was published on
Genome editing is touted as a solution to feeding a planet battered by climate change. But an outdated patent system could stifle its potential.
Swiss open to compromise in Covid vaccine talks at WTO
This content was published on
Switzerland is open to compromise in talks on the IP rights of Covid-19 vaccines and drugs at the World Trade Organization.
Legal victory for Lindt in German chocolate bunny case
This content was published on
The Federal Court of Justice delivered its verdict on Thursday in a battle between Lindt and German company Heilemann, which in 2018 also marketed a chocolate bunny in a gold foil wrap. Lindt claimed it had a trademark on the colour, acquired by use, and that Heilemann had infringed this trademark and should be prevented…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.